Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers
NCT01656356 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL
Last updated 2012-08-08
Summary
The purpose of this study is to evaluate safety and reactogenicity of live attenuated influenza H5 vaccine candidate strain A/17/turkey/Turkey/05/133 (H5N2) manufactured by GPO, in Thailand to previously healthy Thais.
Conditions
- Preventive Avian Flu
Interventions
- BIOLOGICAL
-
Avian Flu Vaccine
- BIOLOGICAL
Sponsors & Collaborators
-
Mahidol University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 49 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-05-31
- Primary Completion
- 2012-08-31
Countries
- Thailand
Study Locations
More Related Trials
-
Evaluation of Priming Effects by PLAI Vaccine on the Subsequent Response to Inactivated H5N1 Vaccine
NCT02229357 ·Status: COMPLETED ·Phase: PHASE2
-
Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults
NCT00516035 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy Thais
NCT01666262 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged 18-64 Years
NCT00771615 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
NCT01045564 ·Status: WITHDRAWN ·Phase: PHASE2
-
H5N1 Priming and Boosting Strategies
NCT00703053 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study of a H5N1 Vaccine in Adults, Elderly and Specified Risk Groups
NCT00711295 ·Status: COMPLETED ·Phase: PHASE3
-
Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses
NCT00417560 ·Status: WITHDRAWN ·Phase: NA
-
Immunogenicity & Safety of GSK's Avian Flu Vaccine 1557484A Given to Adults Aged ≥18 Years
NCT00719043 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity and Safety Study of a GSK Influenza Vaccine Candidate in Adults.
NCT00714285 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Seasonal Influenza Vaccine Against H5N1 Avian Influenza Virus
NCT01044095 ·Status: COMPLETED ·Phase: NA
-
Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Influenza Vaccine in Healthy Thai Adults
NCT03390166 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
NCT01766921 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais
NCT05895955 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Children
NCT01776554 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines
NCT00478816 ·Status: COMPLETED ·Phase: PHASE2
-
Group Study of the Safety of and Immune Response to a Single Dose of Bird Flu Vaccine (H7N3) in Healthy Adults
NCT00853255 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1
NCT01006798 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV
NCT00539864 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
NCT01443663 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity Of A Recombinant H5N1 Vaccine In Adults
NCT01250795 ·Status: COMPLETED ·Phase: PHASE1
-
Safety Study of an Oral Vaccine to Prevent Avian Influenza
NCT01335347 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults
NCT01995695 ·Status: COMPLETED ·Phase: PHASE1
-
Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults
NCT00488046 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine
NCT05056519 ·Status: UNKNOWN ·Phase: PHASE1